Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

NCT02245997 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
78
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Memorial Sloan Kettering Cancer Center